Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin

ClinicalTrials.gov ID: NCT02554877

Public ClinicalTrials.gov record NCT02554877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 12:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether PF-06291874 is effective in the treatment T2DM

Study identification

NCT ID
NCT02554877
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
206 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2015
Primary completion
Jul 31, 2016
Completion
Jul 31, 2016
Last update posted
Aug 6, 2017

2015 – 2016

United States locations

U.S. sites
32
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Anaheim Clinical Trials, LLC Anaheim California 92801
National Research Institute Los Angeles California 90057
NRC Research Institute Orange California 92868
Sierra Clinical Research Roseville California 95661
Encompass Clinical Research Spring Valley California 91978
Empire Clinical Research Upland California 91786
Diablo Clinical Research, Inc Walnut Creek California 94598
Clinical Research of South Florida Coral Gables Florida 33134
Avail Clinical Research, LLC DeLand Florida 32720
Suncoast Research Group, Llc Miami Florida 33135
QPS-MRA, LLC (Miami Research Associates) South Miami Florida 33143
Palm Beach Research Center West Palm Beach Florida 33409
WR-Mount Vernon Clinical Research, LLC Sandy Springs Georgia 30328
East-West Medical Research Institute Honolulu Hawaii 96814
Midwest Institute for Clinical Research Indianapolis Indiana 46260
Crescent City Clinical Research Center, LLC Metairie Louisiana 70006
St. Louis Clinical Trials, LC St Louis Missouri 63141
ALAS Science Clinical Research Las Vegas Nevada 89120
Comprehensive Clinical Research Berlin New Jersey 08009
Clinilabs Inc. Eatontown New Jersey 07724
Pharmaceutical Research Associates, Inc. Marlton New Jersey 08053
TLB Research Trenton New Jersey 08611
Randolph Medical Associates Asheboro North Carolina 27203
High Point Clinical Trials Center, LLC High Point North Carolina 27265
Lillestol Research, LLC Fargo North Dakota 58103
Aventiv Research Columbus Ohio 43213
Juno Research, LLC Houston Texas 77074
Texas Center for Drug Development, Inc. Houston Texas 77081
Juno Research, LLC Katy Texas 77450
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Northeast Clinical Research of San Antonio, LLC Schertz Texas 78154
National Clinical Research - Richmond, Inc. Richmond Virginia 23294

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02554877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2017 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02554877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →